Skip to main content
Toggle navigation
Login
Home
Pharmacovigilance / Cardiovascular
Home
Pharmacovigilance / Cardiovascular
Pharmacovigilance / Cardiovascular
Type here to filter the list
(B-251) Andexanet Alfa and Potential Risk of Thrombotic Events
Favorite
(B-249) DARWIN EU® - Incidence of Myoclonus in Heart Failure: a Descriptive Analysis in Patients Treated with Sacubitril/Valsartan and Other Treatments
Favorite
(A-231) β-Blockers and Risk of Neuropsychiatric Adverse Events: An Active-Comparator Restricted Disproportionality on the FAERS
Favorite
(B-248) Sacubitril-valsartan and Risk of Ototoxicity: A Disproportionality Analysis
Favorite
(B-250) Safety Assessment on the Risk of Liver Dysfunction by ACE Inhibitors utilizing the MID-NET® in Japan
Favorite
(B-247) Understanding the natural history of heart failure by ejection fraction: a systematic review of common comorbidities, readmission rates, and mortality rates
Favorite
